The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-benzyl-4-(2-(benzylamino)ethoxy)indolin-2-one ID: ALA4874675
PubChem CID: 164625686
Max Phase: Preclinical
Molecular Formula: C24H24N2O2
Molecular Weight: 372.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C1Cc2c(OCCNCc3ccccc3)cccc2N1Cc1ccccc1
Standard InChI: InChI=1S/C24H24N2O2/c27-24-16-21-22(26(24)18-20-10-5-2-6-11-20)12-7-13-23(21)28-15-14-25-17-19-8-3-1-4-9-19/h1-13,25H,14-18H2
Standard InChI Key: FMHXVPVWIUUUBY-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
39.0142 -2.3595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0131 -3.1873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4421 -2.3559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7264 -1.9465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1554 -1.9404 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.8719 -2.3504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5851 -1.9351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.3015 -2.3451 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.0147 -1.9296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7312 -2.3397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.7314 -3.1651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.4469 -3.5751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.1611 -3.1597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.1554 -2.3300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.4392 -1.9238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4420 -3.1951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7316 -3.6012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.8984 -4.4024 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.7118 -4.4914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0477 -3.7452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3432 -5.0132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5366 -4.8377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2884 -4.0513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4827 -3.8756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9266 -4.4868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1818 -5.2763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9869 -5.4482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1216 -5.2079 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 17 1 0
16 3 1 0
3 4 2 0
4 1 1 0
3 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
18 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
19 28 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.47Molecular Weight (Monoisotopic): 372.1838AlogP: 3.94#Rotatable Bonds: 8Polar Surface Area: 41.57Molecular Species: BASEHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.41CX Basic pKa: 8.93CX LogP: 3.86CX LogD: 2.33Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.61Np Likeness Score: -0.88
References 1. Wichur T, Godyń J, Góral I, Latacz G, Bucki A, Siwek A, Głuch-Lutwin M, Mordyl B, Śniecikowska J, Walczak M, Knez D, Jukič M, Sałat K, Gobec S, Kołaczkowski M, Malawska B, Brazzolotto X, Więckowska A.. (2021) Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6 R antagonists with β-amyloid anti-aggregation properties., 225 [PMID:34530376 ] [10.1016/j.ejmech.2021.113792 ]